Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation.

Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2012 Dec; 47(12):1552-7.

View in: PubMed

subject areas

Adult
Aged
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Cyclophosphamide
Doxorubicin
Etoposide
Female
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Hodgkin Disease
Humans
Immunosuppressive Agents
Lymphoma, Non-Hodgkin
Male
Middle Aged
Prednisolone
Rituximab
Sirolimus
Transplantation Conditioning
Transplantation, Homologous
Vidarabine
Vincristine
Young Adult

authors with profiles

Michael R. Bishop